Comparison

SLC2A1 Blocking Peptide (C-term)

Item no. ABC-BP19992b
Manufacturer Abcepta
Amount 500 ug
Category
Type Peptides
Format Lyophilized
Specific against other
Citations Mullen, S.A., et al. Neurology 75(5):432-440(2010)
Grabellus, F., et al. J. Nucl. Med. 51(8):1191-1197(2010)
Koda, M., et al. BMC Cancer 10, 320 (2010):
Kim, S.J., et al. J. Exp. Clin. Cancer Res. 29, 69 (2010):
Xiong, Y., et al. Eur. J. Gynaecol. Oncol. 31(2):160-164(2010)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias Solute carrier family 2,facilitated glucose transporter member 1,Glucose transporter type 1,erythrocyte/brain,GLUT-1,HepG2 glucose transporter,SLC2A1,GLUT1
Similar products GLUT1, SLC2A1, Solute carrier family 2, GLUT-1, Glucose transporter type 1, erythrocyte/brain, HepG2 glucose transporter, facilitated glucose transporter member 1
Available
Manufacturer - Category
Peptides; Blocking Peptides
Manufacturer - Targets
The synthetic peptide sequence is selected from aa 453-464 of HUMAN SLC2A1
Bio Background
This gene encodes a major glucose transporter in themammalian blood-brain barrier. Mutations in this gene have beenfound in a family with paroxysmal exertion-induced dyskinesia.
Gene Name
SLC2A1
Subtitle
Synthetic peptide
Formulation
Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 500 ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close